Clincosm LogoSign in Get a demo

Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

Sponsor
University of Virginia (Other)
Overall Status
Unknown status
CT.gov ID
NCT00631553
Collaborator
National Institutes of Health (NIH) (NIH)
20
Enrollment
1
Location
42
Duration (Months)
0.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if contrast enhanced ultrasound (CEU) using microbubbles, is useful in assessing changes in kidney blood flow.

Condition or Disease Intervention/Treatment Phase
  • Drug: perflutren lipid microspheres
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound
Study Start Date :
Jun 1, 2006
Anticipated Study Completion Date :
Dec 1, 2009

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Healthy adults

    • Males and females

    • Ages 18-65 years old

    Exclusion Criteria:

    • Pregnancy or lactation

    • H/o kidney disease

    • H/o congestive heart failure, ischemic heart disease, severe pulmonary disease or allergy to the drug

    • H/o any cardiovascular disease

    • Abnormal liver function (liver function tests out of specified ranges)

    • Screening urinalysis which indicates infection or inflammation

    • Taking regular medications (except for over-the-counter vitamins or hormonal contraceptives.)

    • Taking supplements, like protein shakes

    • Unwilling or unable to eat chicken (used as protein meal)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Virginia Health System Charlottesville Virginia United States 22908

    Sponsors and Collaborators

    • University of Virginia
    • National Institutes of Health (NIH)

    Investigators

    • Principal Investigator: Kambiz Kalantarinia, MD, University of Virginia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00631553
    Other Study ID Numbers:
    • 12014
    First Posted:
    Mar 7, 2008
    Last Update Posted:
    Aug 7, 2008
    Last Verified:
    Aug 1, 2008

    Study Results

    No Results Posted as of Aug 7, 2008